ReNeuron Group plc

ReNeuron Group plc

RNUGF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$62.89K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
ReNeuron Group plcReNeuron Group plc0--525%-0.1

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$62,891.00
Enterprise Value$-4,667,109.00
Earnings per Share$-0.09
Beta0.95
Outstanding Shares57,173,760

Return

Return on Equity-524.74%ROE
Return on Assets-197.79%
Return on Invested Capital-415.98%

Valuation & Multiples

P/E Ratio-0.01P/E Ratio
PEG0.08PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue-4.52
Enterprise Value to EBIT0.43
Enterprise Value to Net Income0
Total Debt to Enterprise-0.07
Debt to Equity0.14Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 20, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Next Earnings Call

Expected Date
May 27, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About ReNeuron Group plc

26 employees
CEO: Iain Gladstone Ross

ReNeuron Group plc is a UK-based biotechnology firm dedicated to the discovery, advancement, and eventual market launch of cutting-edge cell-based medical treatments. Their current pipeline features a CTX stem cell therapy, designed to i...